Published in J Natl Cancer Inst on February 06, 2002
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J Natl Cancer Inst (2012) 11.91
Selling sickness: the pharmaceutical industry and disease mongering. BMJ (2002) 10.98
A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies. Lancet (2012) 3.20
Weight Gain After Breast Cancer Diagnosis and All-Cause Mortality: Systematic Review and Meta-Analysis. J Natl Cancer Inst (2015) 2.12
A different method of evaluation of the ERSPC trial confirms that prostate-specific antigen testing has a significant impact on prostate cancer mortality. Eur Urol (2014) 1.82
Screening trials are even more difficult than we thought they were. J Natl Cancer Inst (2002) 1.76
Death certificates provide an adequate source of cause of death information when evaluating lung cancer mortality: an example from the Mayo Lung Project. Lung Cancer (2008) 1.50
Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis. J Natl Cancer Inst (2009) 1.44
Statistical issues in randomized trials of cancer screening. BMC Med Res Methodol (2002) 1.27
Improving the biomarker pipeline to develop and evaluate cancer screening tests. J Natl Cancer Inst (2009) 1.24
Long-term exposure to NO2 and PM10 and all-cause and cause-specific mortality in a prospective cohort of women. Occup Environ Med (2012) 1.23
Elevated serum transferrin saturation and mortality. Ann Fam Med (2004) 1.22
What is the point: will screening mammography save my life? BMC Med Inform Decis Mak (2009) 1.16
Comparison of 1- and 2-year screening intervals for women undergoing screening mammography. Br J Cancer (2005) 1.16
The National Lung Screening Trial's Endpoint Verification Process: determining the cause of death. Contemp Clin Trials (2011) 1.14
Poverty, hunger, education, and residential status impact survival in HIV. AIDS Behav (2011) 1.05
Profiling of serum and tissue high abundance acute-phase proteins of patients with epithelial and germ line ovarian carcinoma. Proteome Sci (2008) 0.99
Design and preliminary recruitment results of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP). Br J Cancer (2014) 0.96
The mortality risk of elevated serum transferrin saturation and consumption of dietary iron. Ann Fam Med (2004) 0.93
Screening mammography & breast cancer mortality: meta-analysis of quasi-experimental studies. PLoS One (2014) 0.87
Cigarette Smoking Before and After Breast Cancer Diagnosis: Mortality From Breast Cancer and Smoking-Related Diseases. J Clin Oncol (2016) 0.86
Population-based screening for colorectal cancer with faecal occult blood test--do we really have enough evidence? Int J Colorectal Dis (2010) 0.85
Consumption of berries, fruits and vegetables and mortality among 10,000 Norwegian men followed for four decades. Eur J Nutr (2014) 0.85
Tamoxifen chemoprevention treatment and time to first diagnosis of estrogen receptor-negative breast cancer. J Natl Cancer Inst (2008) 0.83
Standardisation of information submitted to an endpoint committee for cause of death assignment in a cancer screening trial – lessons learnt from CAP (Cluster randomised triAl of PSA testing for Prostate cancer). BMC Med Res Methodol (2015) 0.83
Obstructive sleep apnea and the prevalence and incidence of cancer. CMAJ (2014) 0.82
Worldwide Esophageal Cancer Collaboration: neoadjuvant pathologic staging data. Dis Esophagus (2016) 0.81
Interprofessional collaboration and interprofessional education. Br J Gen Pract (2004) 0.81
Screening mammography: what good is it and how can we know if it works? J Natl Cancer Inst (2012) 0.81
Screening for colorectal cancer: decisions in general practice. Br J Gen Pract (2004) 0.81
Balancing influence between actors in healthcare decision making. BMC Health Serv Res (2011) 0.81
Survival of patients with colon and rectal cancer in central and northern Denmark, 1998-2009. Clin Epidemiol (2011) 0.80
Absolute Effect of Prostate Cancer Screening: Balance of Benefits and Harms by Center within the European Randomized Study of Prostate Cancer Screening. Clin Cancer Res (2015) 0.80
Breast cancer screening services: trade-offs in quality, capacity, outreach, and centralization. Health Care Manag Sci (2004) 0.79
Interpreting Clinical Trial Outcomes for Optimal Patient Care: A Survey of Clinicians and Trainees. J Grad Med Educ (2016) 0.79
Endpoint selection and relative (versus absolute) risk reporting in published medication trials. J Gen Intern Med (2011) 0.79
Design of cancer screening trials/randomized trials for evaluation of cancer screening. World J Surg (2006) 0.78
Extended adjuvant tamoxifen for early breast cancer: a meta-analysis. PLoS One (2014) 0.78
Interleukin-8 in neonatal sepsis. Acta Paediatr (2001) 0.78
Impact of venous thromboembolism on mortality of elderly Medicare patients with stage III colon cancer. Oncologist (2012) 0.78
Recommendations for neoadjuvant pathologic staging (ypTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Dis Esophagus (2016) 0.77
Colonoscopy Surveillance after Colorectal Cancer Resection: Recommendations of the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol (2016) 0.76
Re: All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst (2002) 0.75
Evaluation issues in the Swedish Two-County Trial of breast cancer screening: An historical review. J Med Screen (2016) 0.75
Re: All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst (2002) 0.75
Powering cancer screening for overall mortality. Ecancermedicalscience (2013) 0.75
Re: All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst (2002) 0.75
Can suicide in young men be prevented by improving access and delivery among primary care services? Br J Gen Pract (2004) 0.75
Do disease-specific mortality effects correlate with all-cause mortality effects in cancer screening trials? J Fam Pract (2002) 0.75
Appraising the European randomized study of screening for prostate cancer: what do the results mean? Asian J Androl (2015) 0.75
Fungal infection-related mortality versus total mortality as an outcome in trials of antifungal agents. BMC Med Res Methodol (2006) 0.75
Re: All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst (2002) 0.75
Reply to N Karamzad and S Safiri. Am J Clin Nutr (2017) 0.75
Re: All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst (2002) 0.75
Hospital volume and surgical mortality in the United States. N Engl J Med (2002) 25.79
Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA (2006) 22.71
Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med (2012) 13.49
The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst (2005) 8.90
Enthusiasm for cancer screening in the United States. JAMA (2004) 8.22
The natural history of invasive breast cancers detected by screening mammography. Arch Intern Med (2008) 7.37
Surgical mortality as an indicator of hospital quality: the problem with small sample size. JAMA (2004) 4.76
Cervical cancer screening among women without a cervix. JAMA (2004) 3.90
Using a drug facts box to communicate drug benefits and harms: two randomized trials. Ann Intern Med (2009) 3.44
Population-based risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: an analysis of discharge records. Ann Intern Med (2011) 3.38
Regional variations in health care intensity and physician perceptions of quality of care. Ann Intern Med (2006) 3.30
Trends in the use of the pulmonary artery catheter in the United States, 1993-2004. JAMA (2007) 3.23
Risk charts: putting cancer in context. J Natl Cancer Inst (2002) 2.96
State newborn screening in the tandem mass spectrometry era: more tests, more false-positive results. Pediatrics (2006) 2.92
Korea's thyroid-cancer "epidemic"--screening and overdiagnosis. N Engl J Med (2014) 2.74
Observational intensity bias associated with illness adjustment: cross sectional analysis of insurance claims. BMJ (2013) 2.70
The value of benefit data in direct-to-consumer drug ads. Health Aff (Millwood) (2004) 2.68
Tobacco money: up in smoke? Lancet (2002) 2.68
Specialty differences in primary care physician reports of papanicolaou test screening practices: a national survey, 2006 to 2007. Ann Intern Med (2009) 2.67
Screening mammography--a long run for a short slide? N Engl J Med (2010) 2.59
National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. J Vasc Surg (2009) 2.55
Esophageal adenocarcinoma incidence: are we reaching the peak? Cancer Epidemiol Biomarkers Prev (2010) 2.54
The risk of death by age, sex, and smoking status in the United States: putting health risks in context. J Natl Cancer Inst (2008) 2.25
Variation in the tendency of primary care physicians to intervene. Arch Intern Med (2005) 2.17
Electronic patient portals: evidence on health outcomes, satisfaction, efficiency, and attitudes: a systematic review. Ann Intern Med (2013) 2.15
Thyroid cancer survival in the United States: observational data from 1973 to 2005. Arch Otolaryngol Head Neck Surg (2010) 2.14
The increasing incidence of small thyroid cancers: where are the cases coming from? Laryngoscope (2010) 2.01
Advertising by academic medical centers. Arch Intern Med (2005) 1.84
Epidemiology of head and neck cancer in the United States. Otolaryngol Head Neck Surg (2006) 1.71
The frequency of Pap smear screening in the United States. J Gen Intern Med (2004) 1.70
Ratio measures in leading medical journals: structured review of accessibility of underlying absolute risks. BMJ (2006) 1.70
Can patients interpret health information? An assessment of the medical data interpretation test. Med Decis Making (2005) 1.59
U.S. trends in CABG hospital volume: the effect of adding cardiac surgery programs. Health Aff (Millwood) (2007) 1.57
Current antibiotic therapy for isolated urinary tract infections in women. Arch Intern Med (2006) 1.55
Rates of postpartum glucose testing after gestational diabetes mellitus. Obstet Gynecol (2006) 1.50
Repeated upper endoscopy in the Medicare population: a retrospective analysis. Ann Intern Med (2014) 1.50
Overdiagnosis and mammography screening. BMJ (2009) 1.46
The drug facts box: providing consumers with simple tabular data on drug benefit and harm. Med Decis Making (2007) 1.45
Implications of expanding disease definitions: the case of osteoporosis. Health Aff (Millwood) (2007) 1.42
Use of survivorship care plans in the United States: associations with survivorship care. J Natl Cancer Inst (2013) 1.38
Medicare services provided by cardiologists in the United States: 1999-2008. Circ Cardiovasc Qual Outcomes (2012) 1.29
Celebrity endorsements of cancer screening. J Natl Cancer Inst (2005) 1.28
Patients and medical statistics. Interest, confidence, and ability. J Gen Intern Med (2005) 1.27
Too much of a good thing? Physician practices and patient willingness for less frequent pap test screening intervals. Med Care (2010) 1.27
Developing and sustaining quality improvement partnerships in the VA: the Colorectal Cancer Care Collaborative. J Gen Intern Med (2010) 1.25
Ramifications of screening for breast cancer: 1 in 4 cancers detected by mammography are pseudocancers. BMJ (2006) 1.22
Flawed inferences about screening mammography's benefit based on observational data. J Clin Oncol (2008) 1.17
The effectiveness of a primer to help people understand risk: two randomized trials in distinct populations. Ann Intern Med (2007) 1.13
South Korea's Thyroid-Cancer "Epidemic" - Turning the Tide. N Engl J Med (2015) 1.09
The zero mortality paradox in surgery. J Am Coll Surg (2007) 1.09
The sea of uncertainty surrounding ductal carcinoma in situ--the price of screening mammography. J Natl Cancer Inst (2008) 1.00
Impact of diastolic and systolic blood pressure on mortality: implications for the definition of "normal". J Gen Intern Med (2011) 0.99
Not so silver lining. Arch Intern Med (2011) 0.97
Effect of screening mammography on breast cancer incidence. N Engl J Med (2013) 0.96
Provider perceptions of colorectal cancer screening clinical decision support at three benchmark institutions. AMIA Annu Symp Proc (2009) 0.94
Patient-reported quality of supportive care among patients with colorectal cancer in the Veterans Affairs Health Care System. J Clin Oncol (2014) 0.92
Using the results of a baseline and a surveillance colonoscopy to predict recurrent adenomas with high-risk characteristics. Ann Intern Med (2009) 0.92
Trends in Metastatic Breast and Prostate Cancer. N Engl J Med (2016) 0.88
Redesign of a computerized clinical reminder for colorectal cancer screening: a human-computer interaction evaluation. BMC Med Inform Decis Mak (2011) 0.87
Personal health record reach in the Veterans Health Administration: a cross-sectional analysis. J Med Internet Res (2014) 0.84
Risk for increased utilization and adverse health outcomes among men served by the Veterans Health Administration. Mil Med (2007) 0.84
Primary care physician perceptions of adult survivors of childhood cancer. J Pediatr Hematol Oncol (2014) 0.81
Group writing of letters to the editor as the goal of journal club. JAMA (2006) 0.80
Estimating the impact of adding C-reactive protein as a criterion for lipid lowering treatment in the United States. J Gen Intern Med (2007) 0.79
Statins and the risk of colorectal cancer. N Engl J Med (2005) 0.79
Development of a workflow integration survey (WIS) for implementing computerized clinical decision support. AMIA Annu Symp Proc (2011) 0.79
Racial disparities in abdominal aortic aneurysm repair among male Medicare beneficiaries. Arch Surg (2008) 0.78
Factors associated with program utilization of radiation therapy treatment for VHA and medicare dually enrolled patients. J Community Health (2012) 0.78
Small steps or a giant leap for the uninsured? JAMA (2003) 0.78
Short-Term Medical Costs of a VHA Health Information Exchange: A CHEERS-Compliant Article. Medicine (Baltimore) (2016) 0.78
Can internal medicine residents master microscopic urinalysis? Results of an evaluation and teaching intervention. Acad Med (2003) 0.77
Right and wrong reasons to be screened. Ann Intern Med (2004) 0.75
Medication Use among Veterans across Health Care Systems. Appl Clin Inform (2017) 0.75
Colorectal Cancer on the Decline. N Engl J Med (2016) 0.75
Cancer care disparities: research regarding timeliness and potential coordination. Am J Manag Care (2009) 0.75
Search and destroy--the right cancer strategy for Europeans? Eur J Cancer (2005) 0.75